Terms: = Prostate cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Treatment
7 results:
1. Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal treatment of High-risk prostate cancer: A Patient-Level Data Analysis of 3 Cohorts.
Kishan AU; Steigler A; Denham JW; Zapatero A; Guerrero A; Joseph D; Maldonado X; Wong JK; Stish BJ; Dess RT; Pilar A; Reddy C; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Tran PT; Martin S; Martinez-Monge R; Krauss DJ; Abu-Isa EI; Pisansky TM; Choo CR; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Tilki D; Karnes RJ; Tosoian JJ; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Jiang T; Ma TM; Xiang M; Philipson R; Chang A; Kupelian PA; Rettig MB; Feng FY; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Boutros PC; Horwitz EM; Tendulkar RD; Spratt DE; Romero T
JAMA Oncol; 2022 Mar; 8(3):e216871. PubMed ID: 35050303
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of PSA bounce after definitive radiotherapy revisited.
Urabe F; Kimura T; Sasaki H; Tashiro K; Iwatani K; Aoki M; Sato S; Takahashi H; Miki K; Egawa S
Int J Clin Oncol; 2022 Feb; 27(2):411-417. PubMed ID: 34677737
[TBL] [Abstract] [Full Text] [Related]
3. Radiotherapy of prostate cancer in renal transplant recipients: single-center experience.
Gojdic M; Zilinska Z; Krajcovicova I; Lukacko P; Grezdo J; Obsitnik B; Breza J; Trebaticky B
Neoplasma; 2019 Jan; 66(1):155-159. PubMed ID: 30509098
[TBL] [Abstract] [Full Text] [Related]
4. Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer.
Sonpavde G; Huang A; Wang L; Baser O; Miao R
BJU Int; 2018 Jun; 121(6):871-879. PubMed ID: 29388324
[TBL] [Abstract] [Full Text] [Related]
5. The Role of Radical prostatectomy and Radiotherapy in treatment of Locally Advanced prostate cancer: A Systematic Review and Meta-Analysis.
Fahmy O; Khairul-Asri MG; Hadi SHSM; Gakis G; Stenzl A
Urol Int; 2017; 99(3):249-256. PubMed ID: 28675891
[TBL] [Abstract] [Full Text] [Related]
6. Association Between treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk prostate cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract] [Full Text] [Related]
7. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract] [Full Text] [Related]
